News Column

Research Conducted at School of Life Science Has Provided New Information about Clinical Trials and Studies

June 16, 2014

By a News Reporter-Staff News Editor at Clinical Trials Week -- New research on Clinical Research is the subject of a report. According to news reporting originating from Coimbatore, India, by NewsRx correspondents, research stated, "A novel, simple, less time-consuming and cost-effective wet chemical technique was used to synthesis TiO2 nanoparticles and TiO2-SiO2 nanocomposites using Titanium tetra isopropoxide (TTIP) as a precursor relatively at low temperature in acidic pH. Titania sol was prepared by hydrolysis of TTIP and was mixed with silicic acid and tetrahydrofuran mixture."

Our news editors obtained a quote from the research from the School of Life Science, "The reaction was carried out under vigorous stirring for 6 h and dried at room temperature. The resulting powders were characterized by UV-Visible spectroscopy, Fourier transform infrared (FT-IR), X-ray diffraction, scanning electron microscope (SEM) and transmission electron microscope (TEM). The grain size of the particles was calculated by X-ray diffraction, surface morphology and chemical composition was determined from scanning electron microscopy-energy dispersive spectroscopy, metal oxide stretching was confirmed from FT-IR spectroscopy, band gap was calculated using UV-Visible spectroscopy. Surface area of the composite as calculated by BET analyzer and it was found to be 65 and 75 m(2)/g for TiO2 and TiO2-SiO2 respectively."

According to the news editors, the research concluded: "The photocatalytic experiments were performed with aqueous solution of acid red 88 with TiO2 and TiO2-SiO2 batch studies for 4 h irradiation, direct photolysis of TiO2 and TiO2-SiO2 contributed 94.2% and 96.5% decomposition in solar radiation for the optimized concentration of acid red 88."

For more information on this research see: TiO2 nanoparticles versus TiO2-SiO2 nanocomposites: A comparative study of photo catalysis on acid red 88. Spectrochimica Acta Part A-Molecular and Biomolecular Spectroscopy, 2014;128():468-474. Spectrochimica Acta Part A-Molecular and Biomolecular Spectroscopy can be contacted at: Pergamon-Elsevier Science Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, England (see also Clinical Research).

The news editors report that additional information may be obtained by contacting K. Balachandran, Konpagam Univ, Sch Life Sci, Dept. of Biotechnol, Coimbatore 641021, Tamil Nadu, India. Additional authors for this research include R. Venckatesh, R. Sivaraj and P. Rajiv.

Keywords for this news article include: Asia, India, Coimbatore, Nanoparticle, Nanotechnology, Clinical Research, Emerging Technologies, Clinical Trials and Studies

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Clinical Trials Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters